SI-BONE, Inc. Common Stock (SIBN)

Price$13.87

Value ScoreD

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-40.45%

Price vs S&P 500 (4W)1.77%

VGM Score48.03

Market Capitalization$625.32M

All Metrics

Book Value / Share (Quarterly)$4.05

P/TBV (Annual)7.39x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)23.60%

Cash Flow / Share (Quarterly)$-0.13

Price vs S&P 500 (YTD)-39.43%

Gross Margin (TTM)79.59%

Net Profit Margin (TTM)-8.10%

EPS (TTM)$-0.39

10-Day Avg Trading Volume0.58M

EPS Excl Extra (TTM)$-0.39

Revenue Growth (5Y)22.31%

EPS (Annual)$-0.44

ROI (Annual)-8.87%

Gross Margin (Annual)79.57%

Net Profit Margin (5Y Avg)-35.89%

Cash / Share (Quarterly)$3.27

Revenue Growth QoQ (YoY)11.20%

ROA (Last FY)-7.92%

Revenue Growth TTM (YoY)16.77%

EBITD / Share (TTM)$-0.32

ROE (5Y Avg)-31.84%

Operating Margin (TTM)-9.67%

Cash Flow / Share (Annual)$-0.21

P/B Ratio3.49x

P/B Ratio (Quarterly)3.12x

Net Income / Employee (Annual)$-50,300

EV / Revenue (TTM)3.04x

Net Interest Coverage (TTM)-75.63x

ROA (TTM)-7.06%

EPS Incl Extra (Annual)$-0.44

Current Ratio (Annual)8.55x

Quick Ratio (Quarterly)8.17x

3-Month Avg Trading Volume0.65M

52-Week Price Return-25.71%

Revenue / Employee (TTM)$548,500

Tangible BV / Share (Quarterly)$4.30

P/S Ratio (Annual)3.11x

Asset Turnover (Annual)0.84x

52-Week High$21.89

Operating Margin (5Y Avg)-36.39%

EPS Excl Extra (Annual)$-0.44

CapEx CAGR (5Y)26.87%

26-Week Price Return-24.52%

Quick Ratio (Annual)7.03x

13-Week Price Return-13.12%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)9.99x

Enterprise Value$627.39M

Revenue / Share Growth (5Y)13.14%

Asset Turnover (TTM)0.87x

Book Value / Share Growth (5Y)-4.77%

Revenue / Employee (Annual)$534,400

Inventory Turnover (Annual)1.35x

Pretax Margin (Annual)-9.41%

Cash / Share (Annual)$3.39

3-Month Return Std Dev63.47%

Gross Margin (5Y Avg)82.20%

Net Income / Employee (TTM)$-44,400

ROE (Last FY)-10.65%

Net Interest Coverage (Annual)-32.63x

EPS Basic Excl Extra (Annual)$-0.44

Receivables Turnover (TTM)7.15x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$-0.39

Receivables Turnover (Annual)7.00x

ROI (TTM)-7.94%

P/S Ratio (TTM)3.03x

Pretax Margin (5Y Avg)-35.89%

Revenue / Share (Annual)$4.68

Tangible BV / Share (Annual)$2.83

Price vs S&P 500 (52W)-53.92%

Year-to-Date Return-28.50%

5-Day Price Return-3.95%

EPS Normalized (Annual)$-0.44

ROA (5Y Avg)-21.75%

Net Profit Margin (Annual)-9.41%

Month-to-Date Return13.80%

Cash Flow / Share (TTM)$-1.05

EBITD / Share (Annual)$-0.39

Operating Margin (Annual)-11.11%

LT Debt / Equity (Annual)0.20x

P/CF (TTM)333.68x

ROI (5Y Avg)-24.91%

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$-0.39

P/TBV (Quarterly)4.18x

P/B Ratio (Annual)4.82x

Inventory Turnover (TTM)1.28x

Pretax Margin (TTM)-8.10%

Book Value / Share (Annual)$4.07

Price vs S&P 500 (13W)-22.87%

Beta0.71x

Revenue / Share (TTM)$4.69

ROE (TTM)-9.55%

52-Week Low$11.48

vGradeD

gGradeB

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.10est. -0.19

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.19

4.20

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
SIBNSI-BONE, Inc. Common Stock	D	B	D	$13.87
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

SI-BONE Inc. develops and markets minimally invasive surgical implants focused on spine and orthopedic conditions, including its flagship iFuse system for sacroiliac joint fusion. The company's proprietary titanium implants and surgical instruments address high-prevalence conditions such as spinal deformity, degeneration, and pelvic trauma. With operations in the U.S. and internationally, SI-BONE serves the growing orthopedic surgery market through its specialized implant portfolio.